Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Cell Therapy Market, by Therapy Type
1.4.2 Global Cell Therapy Market, by Therapeutic Area
1.4.3 Global Cell Therapy Market, by End User
1.4.4 Global Cell Therapy Market, by Cell Type
1.4.5 Global Cell Therapy Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Approvals & Trials
3.2.5 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
Chapter 4. Global Cell Therapy Market by Therapy Type
4.1 Global Autologous Market by Region
4.2 Global Allogeneic Market by Region
Chapter 5. Global Cell Therapy Market by Therapeutic Area
5.1 Global Malignancies Market by Region
5.2 Global Autoimmune Disorders Market by Region
5.3 Global Musculoskeletal Disorders Market by Region
5.4 Global Dermatology Market by Region
5.5 Global Other Therapeutic Area Market by Region
Chapter 6. Global Cell Therapy Market by End User
6.1 Global Academic & Research Institutes Market by Region
6.2 Global Hospitals & Clinics Market by Region
Chapter 7. Global Cell Therapy Market by Cell Type
7.1 Global Stem Cell Market by Region
7.2 Global Umbilical Cord-Derived Cell Market by Region
7.3 Global Adipose-Derived Stem Cell Market by Region
7.4 Global Non-Stem Cell Market by Region
7.5 Global Bone Marrow Cell Market by Region
7.6 Global Blood Cell Market by Region
7.7 Global Others Cell Market by Region
Chapter 8. Global Cell Therapy Market by Region
8.1 North America Cell Therapy Market
8.1.1 North America Cell Therapy Market by Therapy Type
8.1.1.1 North America Autologous Market by Country
8.1.1.2 North America Allogeneic Market by Country
8.1.2 North America Cell Therapy Market by Therapeutic Area
8.1.2.1 North America Malignancies Market by Country
8.1.2.2 North America Autoimmune Disorders Market by Country
8.1.2.3 North America Musculoskeletal Disorders Market by Country
8.1.2.4 North America Dermatology Market by Country
8.1.2.5 North America Other Therapeutic Area Market by Country
8.1.3 North America Cell Therapy Market by Therapy Type
8.1.3.1 North America Academic & Research Institutes Market by Country
8.1.3.2 North America Hospitals & Clinics Market by Country
8.1.4 North America Cell Therapy Market by Cell Type
8.1.4.1 North America Stem Cell Market by Country
8.1.4.2 North America Umbilical Cord-Derived Cell Market by Country
8.1.4.3 North America Adipose-Derived Stem Cell Market by Country
8.1.4.4 North America Non-Stem Cell Market by Country
8.1.4.5 North America Bone Marrow Cell Market by Country
8.1.4.6 North America Blood Cell Market by Country
8.1.4.7 North America Others Cell Market by Country
8.1.5 North America Cell Therapy Market by Country
8.1.5.1 US Cell Therapy Market
8.1.5.1.1 US Cell Therapy Market by Therapy Type
8.1.5.1.2 US Cell Therapy Market by Therapeutic Area
8.1.5.1.3 US Cell Therapy Market by End User
8.1.5.1.4 US Cell Therapy Market by Cell Type
8.1.5.2 Canada Cell Therapy Market
8.1.5.2.1 Canada Cell Therapy Market by Therapy Type
8.1.5.2.2 Canada Cell Therapy Market by Therapeutic Area
8.1.5.2.3 Canada Cell Therapy Market by End User
8.1.5.2.4 Canada Cell Therapy Market by Cell Type
8.1.5.3 Mexico Cell Therapy Market
8.1.5.3.1 Mexico Cell Therapy Market by Therapy Type
8.1.5.3.2 Mexico Cell Therapy Market by Therapeutic Area
8.1.5.3.3 Mexico Cell Therapy Market by End User
8.1.5.3.4 Mexico Cell Therapy Market by Cell Type
8.1.5.4 Rest of North America Cell Therapy Market
8.1.5.4.1 Rest of North America Cell Therapy Market by Therapy Type
8.1.5.4.2 Rest of North America Cell Therapy Market by Therapeutic Area
8.1.5.4.3 Rest of North America Cell Therapy Market by End User
8.1.5.4.4 Rest of North America Cell Therapy Market by Cell Type
8.2 Europe Cell Therapy Market
8.2.1 Europe Cell Therapy Market by Therapy Type
8.2.1.1 Europe Autologous Market by Country
8.2.1.2 Europe Allogeneic Market by Country
8.2.2 Europe Cell Therapy Market by Therapeutic Area
8.2.2.1 Europe Malignancies Market by Country
8.2.2.2 Europe Autoimmune Disorders Market by Country
8.2.2.3 Europe Musculoskeletal Disorders Market by Country
8.2.2.4 Europe Dermatology Market by Country
8.2.2.5 Europe Other Therapeutic Area Market by Country
8.2.3 Europe Cell Therapy Market by End User
8.2.3.1 Europe Academic & Research Institutes Market by Country
8.2.3.2 Europe Hospitals & Clinics Market by Country
8.2.4 Europe Cell Therapy Market by Cell Type
8.2.4.1 Europe Stem Cell Market by Country
8.2.4.2 Europe Umbilical Cord-Derived Cell Market by Country
8.2.4.3 Europe Adipose-Derived Stem Cell Market by Country
8.2.4.4 Europe Non-Stem Cell Market by Country
8.2.4.5 Europe Bone Marrow Cell Market by Country
8.2.4.6 Europe Blood Cell Market by Country
8.2.4.7 Europe Others Cell Market by Country
8.2.5 Europe Cell Therapy Market by Country
8.2.5.1 Germany Cell Therapy Market
8.2.5.1.1 Germany Cell Therapy Market by Therapy Type
8.2.5.1.2 Germany Cell Therapy Market by Therapeutic Area
8.2.5.1.3 Germany Cell Therapy Market by End User
8.2.5.1.4 Germany Cell Therapy Market by Cell Type
8.2.5.2 UK Cell Therapy Market
8.2.5.2.1 UK Cell Therapy Market by Therapy Type
8.2.5.2.2 UK Cell Therapy Market by Therapeutic Area
8.2.5.2.3 UK Cell Therapy Market by End User
8.2.5.2.4 UK Cell Therapy Market by Cell Type
8.2.5.3 France Cell Therapy Market
8.2.5.3.1 France Cell Therapy Market by Therapy Type
8.2.5.3.2 France Cell Therapy Market by Therapeutic Area
8.2.5.3.3 France Cell Therapy Market by End User
8.2.5.3.4 France Cell Therapy Market by Cell Type
8.2.5.4 Russia Cell Therapy Market
8.2.5.4.1 Russia Cell Therapy Market by Therapy Type
8.2.5.4.2 Russia Cell Therapy Market by Therapeutic Area
8.2.5.4.3 Russia Cell Therapy Market by End User
8.2.5.4.4 Russia Cell Therapy Market by Cell Type
8.2.5.5 Spain Cell Therapy Market
8.2.5.5.1 Spain Cell Therapy Market by Therapy Type
8.2.5.5.2 Spain Cell Therapy Market by Therapeutic Area
8.2.5.5.3 Spain Cell Therapy Market by End User
8.2.5.5.4 Spain Cell Therapy Market by Cell Type
8.2.5.6 Italy Cell Therapy Market
8.2.5.6.1 Italy Cell Therapy Market by Therapy Type
8.2.5.6.2 Italy Cell Therapy Market by Therapeutic Area
8.2.5.6.3 Italy Cell Therapy Market by End User
8.2.5.6.4 Italy Cell Therapy Market by Cell Type
8.2.5.7 Rest of Europe Cell Therapy Market
8.2.5.7.1 Rest of Europe Cell Therapy Market by Therapy Type
8.2.5.7.2 Rest of Europe Cell Therapy Market by Therapeutic Area
8.2.5.7.3 Rest of Europe Cell Therapy Market by End User
8.2.5.7.4 Rest of Europe Cell Therapy Market by Cell Type
8.3 Asia Pacific Cell Therapy Market
8.3.1 Asia Pacific Cell Therapy Market by Therapy Type
8.3.1.1 Asia Pacific Autologous Market by Country
8.3.1.2 Asia Pacific Allogeneic Market by Country
8.3.2 Asia Pacific Cell Therapy Market by Therapeutic Area
8.3.2.1 Asia Pacific Malignancies Market by Country
8.3.2.2 Asia Pacific Autoimmune Disorders Market by Country
8.3.2.3 Asia Pacific Musculoskeletal Disorders Market by Country
8.3.2.4 Asia Pacific Dermatology Market by Country
8.3.2.5 Asia Pacific Other Therapeutic Area Market by Country
8.3.3 Asia Pacific Cell Therapy Market by End User
8.3.3.1 Asia Pacific Academic & Research Institutes Market by Country
8.3.3.2 Asia Pacific Hospitals & Clinics Market by Country
8.3.4 Asia Pacific Cell Therapy Market by Cell Type
8.3.4.1 Asia Pacific Stem Cell Market by Country
8.3.4.2 Asia Pacific Umbilical Cord-Derived Cell Market by Country
8.3.4.3 Asia Pacific Adipose-Derived Stem Cell Market by Country
8.3.4.4 Asia Pacific Non-Stem Cell Market by Country
8.3.4.5 Asia Pacific Bone Marrow Cell Market by Country
8.3.4.6 Asia Pacific Blood Cell Market by Country
8.3.4.7 Asia Pacific Others Cell Market by Country
8.3.5 Asia Pacific Cell Therapy Market by Country
8.3.5.1 China Cell Therapy Market
8.3.5.1.1 China Cell Therapy Market by Therapy Type
8.3.5.1.2 China Cell Therapy Market by Therapeutic Area
8.3.5.1.3 China Cell Therapy Market by End User
8.3.5.1.4 China Cell Therapy Market by Cell Type
8.3.5.2 Japan Cell Therapy Market
8.3.5.2.1 Japan Cell Therapy Market by Therapy Type
8.3.5.2.2 Japan Cell Therapy Market by Therapeutic Area
8.3.5.2.3 Japan Cell Therapy Market by End User
8.3.5.2.4 Japan Cell Therapy Market by Cell Type
8.3.5.3 India Cell Therapy Market
8.3.5.3.1 India Cell Therapy Market by Therapy Type
8.3.5.3.2 India Cell Therapy Market by Therapeutic Area
8.3.5.3.3 India Cell Therapy Market by End User
8.3.5.3.4 India Cell Therapy Market by Cell Type
8.3.5.4 South Korea Cell Therapy Market
8.3.5.4.1 South Korea Cell Therapy Market by Therapy Type
8.3.5.4.2 South Korea Cell Therapy Market by Therapeutic Area
8.3.5.4.3 South Korea Cell Therapy Market by End User
8.3.5.4.4 South Korea Cell Therapy Market by Cell Type
8.3.5.5 Singapore Cell Therapy Market
8.3.5.5.1 Singapore Cell Therapy Market by Therapy Type
8.3.5.5.2 Singapore Cell Therapy Market by Therapeutic Area
8.3.5.5.3 Singapore Cell Therapy Market by End User
8.3.5.5.4 Singapore Cell Therapy Market by Cell Type
8.3.5.6 Malaysia Cell Therapy Market
8.3.5.6.1 Malaysia Cell Therapy Market by Therapy Type
8.3.5.6.2 Malaysia Cell Therapy Market by Therapeutic Area
8.3.5.6.3 Malaysia Cell Therapy Market by End User
8.3.5.6.4 Malaysia Cell Therapy Market by Cell Type
8.3.5.7 Rest of Asia Pacific Cell Therapy Market
8.3.5.7.1 Rest of Asia Pacific Cell Therapy Market by Therapy Type
8.3.5.7.2 Rest of Asia Pacific Cell Therapy Market by Therapeutic Area
8.3.5.7.3 Rest of Asia Pacific Cell Therapy Market by End User
8.3.5.7.4 Rest of Asia Pacific Cell Therapy Market by Cell Type
8.4 LAMEA Cell Therapy Market
8.4.1 LAMEA Cell Therapy Market by Therapy Type
8.4.1.1 LAMEA Autologous Market by Country
8.4.1.2 LAMEA Allogeneic Market by Country
8.4.2 LAMEA Cell Therapy Market by Therapeutic Area
8.4.2.1 LAMEA Malignancies Market by Country
8.4.2.2 LAMEA Autoimmune Disorders Market by Country
8.4.2.3 LAMEA Musculoskeletal Disorders Market by Country
8.4.2.4 LAMEA Dermatology Market by Country
8.4.2.5 LAMEA Other Therapeutic Area Market by Country
8.4.3 LAMEA Cell Therapy Market by End User
8.4.3.1 LAMEA Academic & Research Institutes Market by Country
8.4.3.2 LAMEA Hospitals & Clinics Market by Country
8.4.3.3 LAMEA Cell Therapy Market by Cell Type
8.4.3.4 LAMEA Stem Cell Market by Country
8.4.3.5 LAMEA Umbilical Cord-Derived Cell Market by Country
8.4.3.6 LAMEA Adipose-Derived Stem Cell Market by Country
8.4.3.7 LAMEA Non-Stem Cell Market by Country
8.4.3.8 LAMEA Bone Marrow Cell Market by Country
8.4.3.9 LAMEA Blood Cell Market by Country
8.4.3.10 LAMEA Others Cell Market by Country
8.4.4 LAMEA Cell Therapy Market by Country
8.4.4.1 Brazil Cell Therapy Market
8.4.4.1.1 Brazil Cell Therapy Market by Therapy Type
8.4.4.1.2 Brazil Cell Therapy Market by Therapeutic Area
8.4.4.1.3 Brazil Cell Therapy Market by End User
8.4.4.1.4 Brazil Cell Therapy Market by Cell Type
8.4.4.2 Argentina Cell Therapy Market
8.4.4.2.1 Argentina Cell Therapy Market by Therapy Type
8.4.4.2.2 Argentina Cell Therapy Market by Therapeutic Area
8.4.4.2.3 Argentina Cell Therapy Market by End User
8.4.4.2.4 Argentina Cell Therapy Market by Cell Type
8.4.4.3 UAE Cell Therapy Market
8.4.4.3.1 UAE Cell Therapy Market by Therapy Type
8.4.4.3.2 UAE Cell Therapy Market by Therapeutic Area
8.4.4.3.3 UAE Cell Therapy Market by End User
8.4.4.3.4 UAE Cell Therapy Market by Cell Type
8.4.4.4 Saudi Arabia Cell Therapy Market
8.4.4.4.1 Saudi Arabia Cell Therapy Market by Therapy Type
8.4.4.4.2 Saudi Arabia Cell Therapy Market by Therapeutic Area
8.4.4.4.3 Saudi Arabia Cell Therapy Market by End User
8.4.4.4.4 Saudi Arabia Cell Therapy Market by Cell Type
8.4.4.5 South Africa Cell Therapy Market
8.4.4.5.1 South Africa Cell Therapy Market by Therapy Type
8.4.4.5.2 South Africa Cell Therapy Market by Therapeutic Area
8.4.4.5.3 South Africa Cell Therapy Market by End User
8.4.4.5.4 South Africa Cell Therapy Market by Cell Type
8.4.4.6 Nigeria Cell Therapy Market
8.4.4.6.1 Nigeria Cell Therapy Market by Therapy Type
8.4.4.6.2 Nigeria Cell Therapy Market by Therapeutic Area
8.4.4.6.3 Nigeria Cell Therapy Market by End User
8.4.4.6.4 Nigeria Cell Therapy Market by Cell Type
8.4.4.7 Rest of LAMEA Cell Therapy Market
8.4.4.7.1 Rest of LAMEA Cell Therapy Market by Therapy Type
8.4.4.7.2 Rest of LAMEA Cell Therapy Market by Therapeutic Area
8.4.4.7.3 Rest of LAMEA Cell Therapy Market by End User
8.4.4.7.4 Rest of LAMEA Cell Therapy Market by Cell Type
Chapter 9. Company Profiles
9.1 Fujifilm Holdings Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Geographical Expansions:
9.2 Smith & Nephew PLC
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.2.5.2 Acquisition and Mergers:
9.3 Kolon TissueGene, Inc.
9.3.1 Company Overview
9.3.2 Recent strategies and developments:
9.3.2.1 Approvals & Trials:
9.4 JCR Pharmaceuticals Co., Ltd.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Research & Development Expense
9.4.4 Recent strategies and developments:
9.4.4.1 Partnerships, Collaborations, and Agreements:
9.4.4.2 Acquisition and Mergers:
9.4.4.3 Approvals & Trials:
9.5 Medipost Co., Ltd.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Recent strategies and developments:
9.5.3.1 Partnerships, Collaborations, and Agreements:
9.5.3.2 Approvals & Trials:
9.6 Stemedica Cell Technologies, Inc.
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Approvals & Trials:
9.7 NuVasive, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Product Launches and Product Expansions:
9.8 Avantor, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Product Launches and Product Expansions:
9.8.4.2 Geographical Expansions:
9.9 Vericel Corporation
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Research & Development Expense
9.9.4 Recent strategies and developments:
9.9.4.1 Partnerships, Collaborations, and Agreements:
9.9.4.2 Product Launches and Product Expansions:
9.1 Pharmicell Co., Ltd.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Research & Development Expense
9.10.4 Recent strategies and developments:
9.10.4.1 Partnerships, Collaborations, and Agreements:
Unique Offerings 